vs
ICU MEDICAL INC（ICUI）与Reynolds Consumer Products Inc.（REYN）财务数据对比。点击上方公司名可切换其他公司
Reynolds Consumer Products Inc.的季度营收约是ICU MEDICAL INC的1.9倍（$1.0B vs $540.7M），Reynolds Consumer Products Inc.净利率更高（11.4% vs -2.9%，领先14.3%），Reynolds Consumer Products Inc.同比增速更快（1.2% vs -14.1%），Reynolds Consumer Products Inc.自由现金流更多（$200.0M vs $36.0M），过去两年Reynolds Consumer Products Inc.的营收复合增速更高（11.4% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
雷诺消费品公司旗下的Rival是美国小家电制造商，拥有Bionaire、Crock-Pot、Rival等多个知名品牌。1999年成为Holmes产品集团全资子公司，2005年随Holmes被Jarden收购，后Jarden与纽威尔橡胶美合并，现隶属于纽威尔集团。
ICUI vs REYN — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $1.0B |
| 净利润 | $-15.7M | $118.0M |
| 毛利率 | 37.5% | 25.7% |
| 营业利润率 | 1.0% | 14.8% |
| 净利率 | -2.9% | 11.4% |
| 营收同比 | -14.1% | 1.2% |
| 净利润同比 | 34.0% | -1.7% |
| 每股收益（稀释后） | $-0.63 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $1.0B | ||
| Q3 25 | $537.0M | $931.0M | ||
| Q2 25 | $548.9M | $938.0M | ||
| Q1 25 | $604.7M | $818.0M | ||
| Q4 24 | $629.8M | $1.0B | ||
| Q3 24 | $589.1M | $910.0M | ||
| Q2 24 | $596.5M | $930.0M | ||
| Q1 24 | $566.7M | $833.0M |
| Q4 25 | $-15.7M | $118.0M | ||
| Q3 25 | $-3.4M | $79.0M | ||
| Q2 25 | $35.3M | $73.0M | ||
| Q1 25 | $-15.5M | $31.0M | ||
| Q4 24 | $-23.8M | $120.0M | ||
| Q3 24 | $-33.0M | $86.0M | ||
| Q2 24 | $-21.4M | $97.0M | ||
| Q1 24 | $-39.5M | $49.0M |
| Q4 25 | 37.5% | 25.7% | ||
| Q3 25 | 37.4% | 25.0% | ||
| Q2 25 | 37.9% | 24.1% | ||
| Q1 25 | 34.7% | 23.1% | ||
| Q4 24 | 36.1% | 27.6% | ||
| Q3 24 | 34.8% | 26.3% | ||
| Q2 24 | 34.8% | 27.5% | ||
| Q1 24 | 32.7% | 24.1% |
| Q4 25 | 1.0% | 14.8% | ||
| Q3 25 | 2.6% | 11.0% | ||
| Q2 25 | 1.9% | 10.2% | ||
| Q1 25 | 2.1% | 5.1% | ||
| Q4 24 | 6.0% | 15.5% | ||
| Q3 24 | 1.4% | 12.4% | ||
| Q2 24 | 1.3% | 12.4% | ||
| Q1 24 | -1.9% | 7.8% |
| Q4 25 | -2.9% | 11.4% | ||
| Q3 25 | -0.6% | 8.5% | ||
| Q2 25 | 6.4% | 7.8% | ||
| Q1 25 | -2.6% | 3.8% | ||
| Q4 24 | -3.8% | 11.7% | ||
| Q3 24 | -5.6% | 9.5% | ||
| Q2 24 | -3.6% | 10.4% | ||
| Q1 24 | -7.0% | 5.9% |
| Q4 25 | $-0.63 | $0.55 | ||
| Q3 25 | $-0.14 | $0.38 | ||
| Q2 25 | $1.43 | $0.35 | ||
| Q1 25 | $-0.63 | $0.15 | ||
| Q4 24 | $-0.97 | $0.57 | ||
| Q3 24 | $-1.35 | $0.41 | ||
| Q2 24 | $-0.88 | $0.46 | ||
| Q1 24 | $-1.63 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $147.0M |
| 总债务越低越好 | — | $1.6B |
| 股东权益账面价值 | $2.1B | $2.3B |
| 总资产 | $4.1B | $4.9B |
| 负债/权益比越低杠杆越低 | — | 0.70× |
8季度趋势，按日历期对齐
| Q4 25 | — | $147.0M | ||
| Q3 25 | — | $53.0M | ||
| Q2 25 | — | $57.0M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | $308.6M | $137.0M | ||
| Q3 24 | $312.5M | $96.0M | ||
| Q2 24 | $302.6M | $101.0M | ||
| Q1 24 | $251.4M | $135.0M |
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | $2.1B | $2.3B | ||
| Q3 25 | $2.1B | $2.2B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $2.0B | $2.0B | ||
| Q1 24 | $2.1B | $2.0B |
| Q4 25 | $4.1B | $4.9B | ||
| Q3 25 | $4.1B | $4.9B | ||
| Q2 25 | $4.1B | $4.9B | ||
| Q1 25 | $4.2B | $4.8B | ||
| Q4 24 | $4.2B | $4.9B | ||
| Q3 24 | $4.3B | $4.8B | ||
| Q2 24 | $4.3B | $4.9B | ||
| Q1 24 | $4.3B | $4.9B |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 0.92× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $237.0M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $200.0M |
| 自由现金流率自由现金流/营收 | 6.6% | 19.3% |
| 资本支出强度资本支出/营收 | 4.6% | 3.6% |
| 现金转化率经营现金流/净利润 | — | 2.01× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $316.0M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $237.0M | ||
| Q3 25 | $56.7M | $93.0M | ||
| Q2 25 | $11.2M | $91.0M | ||
| Q1 25 | $51.3M | $56.0M | ||
| Q4 24 | $40.2M | $182.0M | ||
| Q3 24 | $36.1M | $124.0M | ||
| Q2 24 | $82.0M | $84.0M | ||
| Q1 24 | $45.8M | $99.0M |
| Q4 25 | $36.0M | $200.0M | ||
| Q3 25 | $27.6M | $48.0M | ||
| Q2 25 | $-8.5M | $51.0M | ||
| Q1 25 | $36.7M | $17.0M | ||
| Q4 24 | $16.1M | $141.0M | ||
| Q3 24 | $16.2M | $93.0M | ||
| Q2 24 | $62.5M | $65.0M | ||
| Q1 24 | $29.9M | $70.0M |
| Q4 25 | 6.6% | 19.3% | ||
| Q3 25 | 5.1% | 5.2% | ||
| Q2 25 | -1.5% | 5.4% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | 2.6% | 13.8% | ||
| Q3 24 | 2.7% | 10.2% | ||
| Q2 24 | 10.5% | 7.0% | ||
| Q1 24 | 5.3% | 8.4% |
| Q4 25 | 4.6% | 3.6% | ||
| Q3 25 | 5.4% | 4.8% | ||
| Q2 25 | 3.6% | 4.3% | ||
| Q1 25 | 2.4% | 4.8% | ||
| Q4 24 | 3.8% | 4.0% | ||
| Q3 24 | 3.4% | 3.4% | ||
| Q2 24 | 3.3% | 2.0% | ||
| Q1 24 | 2.8% | 3.5% |
| Q4 25 | — | 2.01× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | 0.32× | 1.25× | ||
| Q1 25 | — | 1.81× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 2.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
REYN
| Reynolds Cooking And Baking | $397.0M | 38% |
| Hefty Waste And Storage | $247.0M | 24% |
| Tableware Products | $229.0M | 22% |
| Presto Products | $164.0M | 16% |
